Table 3.
Simple | Multiple | Best AIC | |||||||
---|---|---|---|---|---|---|---|---|---|
Characteristic | Beta | 95% CI | p-Value | Beta | 95% CI | p-Value | Beta | 95% CI1 | p-Value |
Age | 0.10 | −0.17, 0.36 | 0.476 | −0.05 | −0.18, 0.08 | 0.412 | |||
Sex | −1.3 | −4.1, 1.6 | 0.382 | 0.41 | −1.2, 2.1 | 0.621 | |||
Polypharmacy | 26 | 24, 28 | <0.001 | 21 | 19, 22 | <0.001 | 21 | 20, 23 | <0.001 |
Excessive polypharmacy | 39 | 35, 43 | <0.001 | 27 | 24, 29 | <0.001 | 27 | 24, 29 | <0.001 |
Chronic diseases | 12 | 7.9, 16 | <0.001 | 3.5 | 1.2, 5.8 | 0.003 | 3.6 | 1.5, 5.7 | <0.001 |
Hypertension | 8.3 | 5.6, 11 | <0.001 | 0.28 | −1.3, 1.8 | 0.723 | |||
Dyslipidemia | 8.2 | 5.4, 11 | <0.001 | −0.32 | −1.9, 1.2 | 0.686 | |||
Diabetes mellitus | 12 | 8.4, 15 | <0.001 | 1.1 | −0.63, 2.8 | 0.214 | |||
High-risk medications | 13 | 10, 16 | <0.001 | 3.2 | 1.0, 5.3 | 0.004 | 2.9 | 1.1, 4.8 | 0.002 |
Abbreviations: CI, confidence interval; AIC, Akaike Information Criterion.